4B1A image
Deposition Date 2012-07-09
Release Date 2013-02-06
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4B1A
Keywords:
Title:
Crystal structure of lysozyme with Keggin molecule
Biological Source:
Source Organism:
GALLUS GALLUS (Taxon ID: 9031)
Method Details:
Experimental Method:
Resolution:
1.67 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:LYSOZYME C
Gene (Uniprot):LYZ
Chain IDs:A
Chain Length:129
Number of Molecules:1
Biological Source:GALLUS GALLUS
Primary Citation
Characterization of a Versatile Organometallic Pro-Drug (Corm) for Experimental Co Based Therapeutics.
Dalton Trans 42 5985 ? (2013)
PMID: 23223860 DOI: 10.1039/C2DT32174B

Abstact

The complex fac-[Mo(CO)(3)(histidinate)]Na has been reported to be an effective CO-Releasing Molecule in vivo, eliciting therapeutic effects in several animal models of disease. The CO releasing profile of this complex in different settings both in vitro and in vivo reveals that the compound can readily liberate all of its three CO equivalents under biological conditions. The compound has low toxicity and cytotoxicity and is not hemolytic. CO release is accompanied by a decrease in arterial blood pressure following administration in vivo. We studied its behavior in solution and upon the interaction with proteins. Reactive oxygen species (ROS) generation upon exposure to air and polyoxomolybdate formation in soaks with lysozyme crystals were observed as processes ensuing from the decomposition of the complex and the release of CO.

Legend

Protein

Chemical

Disease

Primary Citation of related structures